Biotech Weakness Outpaces Decline on Nasdaq (IBB)
Tweet
Share
E-mailThe Nasdaq biotech index and its related ETF (NASDAQ: IBB) were lower by over 1% mid-morning while the composite index traded lower by only 0.3%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US government plans $4 billion loan to Vistra for nuclear upgrades - Bloomberg
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Ethos Technologies (LIFE) Mentioned Cautiously at Bear Cave
Create E-mail Alert Related Categories
ETFs, Market Check, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
